There were 127 press releases posted in the last 24 hours and 440,199 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
B.More Receives FDA Investigational New Drug Approval for Psilocybin Alcohol Use Disorder Program Phase 2b Clinical Trial

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image